Stifel Financial’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.84M | Buy |
111,925
+4,826
| +5% | +$410K | 0.01% | 1085 |
|
|
2026
Q1 | $9.23M | Buy |
107,099
+32,790
| +44% | +$2.94M | 0.01% | 1002 |
|
|
2025
Q4 | $6.49M | Sell |
74,309
-88,997
| -54% | -$6.75M | 0.01% | 1186 |
|
|
2025
Q3 | $9.35M | Buy |
163,306
+81,125
| +99% | +$4.67M | 0.01% | 981 |
|
|
2025
Q2 | $4.85M | Buy |
82,181
+12,112
| +17% | +$783K | ﹤0.01% | 1269 |
|
|
2025
Q1 | $5.13M | Buy |
70,069
+12,435
| +22% | +$1.03M | 0.01% | 1182 |
|
|
2024
Q4 | $4.77M | Buy |
57,634
+4,799
| +9% | +$378K | 0.01% | 1226 |
|
|
2024
Q3 | $3.78M | Buy |
52,835
+306
| +0.6% | +$21.6K | ﹤0.01% | 1363 |
|
|
2024
Q2 | $3.6M | Buy |
52,529
+6,714
| +15% | +$401K | ﹤0.01% | 1333 |
|
|
2024
Q1 | $2.46M | Buy |
45,815
+6,125
| +15% | +$329K | ﹤0.01% | 1575 |
|
|
2023
Q4 | $2.12M | Sell |
39,690
-7,532
| -16% | -$367K | ﹤0.01% | 1629 |
|
|
2023
Q3 | $2.34M | Buy |
47,222
+42,535
| +908% | +$2.38M | ﹤0.01% | 1487 |
|
|
2023
Q2 | $279K | Sell |
4,687
-493
| -10% | -$28.1K | ﹤0.01% | 2863 |
|
|
2023
Q1 | $293K | Sell |
5,180
-198,575
| -97% | -$12.7M | ﹤0.01% | 2832 |
|
|
2022
Q4 | $15.1M | Buy |
203,755
+66,442
| +48% | +$4.52M | 0.02% | 540 |
|
|
2022
Q3 | $8.18M | Sell |
137,313
-22,163
| -14% | -$1.33M | 0.01% | 710 |
|
|
2022
Q2 | $8.95M | Buy |
159,476
+131,325
| +467% | +$8.63M | 0.01% | 699 |
|
|
2022
Q1 | $2.08M | Buy |
28,151
+1,983
| +8% | +$138K | ﹤0.01% | 1589 |
|
|
2021
Q4 | $1.89M | Buy |
26,168
+168
| +0.6% | +$12.2K | ﹤0.01% | 1659 |
|
|
2021
Q3 | $1.99M | Buy |
26,000
+21,729
| +509% | +$1.74M | ﹤0.01% | 1583 |
|
|
2021
Q2 | $331K | Buy |
+4,271
| New | +$304K | ﹤0.01% | 2836 |
|
|
2020
Q1 | – | Sell |
-7,142
| Closed | -$418K | – | 2918 |
|
|
2019
Q4 | $418K | Buy |
7,142
+819
| +13% | +$44.5K | ﹤0.01% | 2369 |
|
|
2019
Q3 | $324K | Sell |
6,323
-5,917
| -48% | -$282K | ﹤0.01% | 2403 |
|
|
2019
Q2 | $519K | Sell |
12,240
-2,783
| -19% | -$121K | ﹤0.01% | 2179 |
|
|
2019
Q1 | $742K | Buy |
15,023
+9,823
| +189% | +$444K | ﹤0.01% | 1838 |
|
|
2018
Q4 | $225K | Hold |
5,200
| – | – | ﹤0.01% | 2401 |
|
|
2018
Q3 | $295K | Sell |
5,200
-67
| -1% | -$3.53K | ﹤0.01% | 2372 |
|
|
2018
Q2 | $265K | Sell |
5,267
-7,488
| -59% | -$390K | ﹤0.01% | 2375 |
|
|
2018
Q1 | $635K | Sell |
12,755
-7,142
| -36% | -$336K | ﹤0.01% | 1832 |
|
|
2017
Q4 | $812K | Buy |
19,897
+4,270
| +27% | +$149K | ﹤0.01% | 1644 |
|
|
2017
Q3 | $461K | Sell |
15,627
-820
| -5% | -$25K | ﹤0.01% | 1930 |
|
|
2017
Q2 | $544K | Sell |
16,447
-6,165
| -27% | -$194K | ﹤0.01% | 1816 |
|
|
2017
Q1 | $668K | Sell |
22,612
-33
| -0.1% | -$901 | ﹤0.01% | 1657 |
|
|
2016
Q4 | $560K | Buy |
22,645
+7,262
| +47% | +$165K | ﹤0.01% | 1716 |
|
|
2016
Q3 | $348K | Buy |
+15,383
| New | +$362K | ﹤0.01% | 1915 |
|
Other funds holding GMED
JT
SC
Stifel Financial's GMED Position: Q2 2026 in Review
Stifel Financial increased its Globus Medical (GMED) stake by 4.5% in Q2 2026, buying an estimated $410K and bringing the position to 111,925 shares worth $8.84M. The position accounts for 0.01% of the portfolio, ranked #1085.
Stifel Financial first reported a position in GMED in Q3 2016 and has held it in 35 quarters since. The position peaked at $15.1M in Q4 2022. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Stifel Financial held 111,925 shares of Globus Medical worth $8.84M as of Q2 2026.
- Stifel Financial bought 4,826 Globus Medical shares in Q2 2026, an estimated $410K.
- Globus Medical made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #1085 holding.
- Stifel Financial first reported a position in Globus Medical in Q3 2016 and has held it in 35 quarters since.
- Stifel Financial's Globus Medical position peaked at $15.1M in Q4 2022.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.